Nephro Star Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1.48%
- Profit Growth 134.81%
- Ebitda 242.90%
- Net Worth 3.56%
- Total Assets -29.96%
About Nephro Star Healthcare
Nephro Star Healthcare Private Limited (NSHPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2016 (Nine years and one month 15 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammad Mubeen, Mohd Ayyub, and Salma Parveen serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2016PTC289137
-
Company No.
289137
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jan 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Nephro Star Healthcare Private Limited offer?
Nephro Star Healthcare Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Pharmaceutical Medicine, Kidney Drugs, Mineral Supplement.
Who are the key members and board of directors at Nephro Star Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammad Mubeen
|
Director | 01-Jan-2016 | Current |
|
Mohd Ayyub
|
Additional Director | 04-Apr-2018 | Current |
|
Salma Parveen
|
Director | 01-Jan-2016 | Current |
Financial Performance of Nephro Star Healthcare.
Nephro Star Healthcare Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.48% increase. The company also saw a substantial improvement in profitability, with a 134.81% increase in profit. The company's net worth moved up by a moderate rise of 3.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nephro Star Healthcare?
In 2017, Nephro Star Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nephro Star Healthcare?
Unlock and access historical data on people associated with Nephro Star Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nephro Star Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephro Star Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.